Shiferman Gregory L.

Shiferman Gregory L. is listed in filings as SVP and General Counsel at Voyager Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 3, 2026, including 16 public disclosures. Recent filings connect the profile to Voyager Therapeutics, Inc. (VYGR) and Sage Therapeutics, Inc. (SAGE). The current snapshot covers public activity from Nov 1, 2024 to Apr 3, 2026. Reported amounts are shown as $402.0K to $60.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.